Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 9378  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  [PDF Not available] *
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 


  IN THIS Article
 ::  Introduction
 ::  Material and methods
 ::  Results
 ::  Discussion
 ::  References

 Article Access Statistics
    Viewed5105    
    Printed68    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


   
Year : 1985  |  Volume : 31  |  Issue : 3  |  Page : 150-4

Comparative clinical study of enfenamic acid and aspirin in rheumatoid arthritis.







How to cite this article:
Gupta S R, Kaushik A A, Sharma V V, Kulshrestha V K. Comparative clinical study of enfenamic acid and aspirin in rheumatoid arthritis. J Postgrad Med 1985;31:150


How to cite this URL:
Gupta S R, Kaushik A A, Sharma V V, Kulshrestha V K. Comparative clinical study of enfenamic acid and aspirin in rheumatoid arthritis. J Postgrad Med [serial online] 1985 [cited 2019 Nov 17];31:150. Available from: http://www.jpgmonline.com/text.asp?1985/31/3/150/5401




  ::   Introduction Top

Enfenamic acid, N-phenylethyl anthranilic acid, has been recently introduced as a non-steroidal anti-inflammatory drug. In experimental animals, the drug is reported to possess anti-inflammatory, analgesic and anti-pyretic activity with negligible ulcerogenic activity.[10] Acute and chronic toxicity studies conducted in rats and mice have shown it to be safe.[10] The drug was also evaluated clinically on these parameters.[2],[3],[6],[7],[12] Enfenamic acid was found to be an effective anti-inflammatory agent with good tolerance and minimal side effects.[11] Therefore, a comparative evaluation of enfenamic acid and aspirin was undertaken in diagnosed cases of arthritis.

  ::   Material and methods Top

Twenty patients (8 males and 12 females) of different types of rheumatoid arthritis whose duration of disease was at least 6 months and who were admitted in the M.L.B. Medical College Hospital were selected for the study. Cut of these, 8 patients were of juvenile rheumatoid arthritis (4 polyarticular type, 3 pauci articular type and one systemic type) with mean age of 7 years and 12 were of adult type of rheumatoid arthritis with mean age of 32 years. Criteria, laid down by American Rheumatism Association[4] (revised in 1963) were used for the diagnosis. According to these criteria, 9 cases were classical, 7 were definite and 4 were probable for rheumatoid arthritis. Patient were divided randomly into two groups of 10 patients each, having equal number (4 patients) of juvenile rheumatoid arthritis in each group and a non-crossover double blind clinical trial with aspirin (standard drug) and enfenamic acid was undertaken. A thorough clinical examination of the patients regarding classical features of the disease was carefully done. However, patients reporting symptoms like nausea, vomiting, epigastric pain, haematemesis and melaena were excluded from the study. All the previous medication was discontinued at least seven days before the trial. Aspirin and enfenamic acid were administered in daily doses of 2.4 g and 1.6 g respectively in identical looking capsules three times a day after food. Patients receiving either drug were examined daily for any adverse effects. No other drug was used concurrently during this period. Response of treatment was recorded after intervals of two and four weeks. Evaluation of digital joint circumference (P.I.P.), duration of morning stiffness, gripstrength, degree of pain, walking time, fever and E.S.R. was done before the treatment and at the end of 2 and 4, weeks of treatment. Adverse effects experienced by the patients during the treatment period were also recorded.
(a) Grip-strength
The assessment of grip-strength was done by the effort of the patient to raise the level of mercury column by squeezing the rubber ball.[8]
(b) Digital-joint circumference (P.I.P.)
P.I.P. circumference was recorded with the help of a measuring tape.[5]
(c) Walking time
It was evaluated by recording the time taken by the patient to walk down the distance of 50 feet.[10]
(d) Assessment of pain
Subjective assessment of pain was done by the method of Punjabi et al.[6] The degree of severity of pain was scored as 0,1,2,3.
(e) Fever
The anti-pyretic activity was evaluated by using the clinical thermometer. The variations in average body temperature were recorded before treatment and after an interval of half, 3, 6 and 8 hours following drug administration.
(f) E.S.R.
It was measured by the method of Wintrobe.[13]
(g) Side effects
Drug induced adverse effects were regularly recorded during the period of drug treatment.
The data obtained in the present study was analysed statistically by the Student's 't' test. Wilcoxon sign rank test was applied in non-parametric data.

  ::   Results Top

Grip:-strength, walking time and digital joint circumference
[Table - 1] shows that both, aspirin and enfenamic acid, produced gradual and significant decrease in walking time and digital joint circumference. However, aspirin showed highly significant increase in grip-strength compared to enfenamic acid.
Morning-stiffness
Both the drugs elicited a gradual and significant decrease in the duration of morning stiffness after one and two weeks of therapy. However, aspirin, as compared to enfenamic acid resulted in highly significant effect at the end of two weeks of therapy (p < 0.001).
E.S.R.
After 4 weeks of treatment, aspirin treated patients showed a significant fall in E.S.R. from 53.40 5.32 to 29.82 3.77 (p < 0.01). However, enfenamic acid failed to show any significant change in this parameter.
Subjective assessment of pain
A significant improvement in the subjective assessment of pain sensation was recorded in both aspirin and enfenamic acid treated groups after two weeks of therapy. In aspirin treated group, the fall was from 2.8 0.13 to 0.84 0.16 while in enfenamic acid treated group, it was from 2.5 0.16 to 1.2 0.20. However, aspirin appeared to be more effective than enfenamic acid in this study (p < 0.001).
Fever
The peak effect of antipyretic activity in aspirin treated groups was attained after 3 hours and was highly significant (p < 0.001) than enfenamic acid and persisted for 8 hours of study. However, enfenamic acid also showed diminution in average body temperature which, though significant at the end of 3 hours, showed an upward trend beyond this period [Table - 2].
Side effects
During the period of observation, aspirin showed greater potentiality for adverse effects than enfenamic acid. In the enfenamic acid treated group, three patients complained of nausea, one of vomiting and one of burning sensation in the epigastrium while in the aspirin treated group, five complained of nausea, and two each of vomiting, burning sensation and melaena.

  ::   Discussion Top

In the previous studies by Sattur et al[9] and Rao et al,[8] enfenamic acid has been shown to produce improvement in all the parameters studied in patients of arthritis. In the present study also, enfenamic acid as well as aspirin produced significant improvement in patients having arthritis. On comparison, aspirin and enfenamic acid were found to be equi-effective on parameters like walking time and digital joint circumference. However, in the present study, aspirin was found to be superior in improving grip-strength and reducing morning stiffness and E.S.R. as compared to enfenamic acid. Aspirin also showed more marked analgesic action than enfenamic acid. In our study, both the drugs were found to possess anti-pyretic effect but reduction in temperature was not comparable as reported by Gupta et al,[1] as aspirin was found to be more effective in this respect. However, we found enfenamic acid to be better tolerated in comparison to aspirin as adverse effects were observed more frequently with aspirin. Thus, both aspirin and enfenamic acid are effective in rheumatoid arthritis but on some of the parameters studied, aspirin had more effect.

  ::   References Top

1.Gupta. Kusum, C., Paul, T., Bodani, P. V. and Sheth, U. K.: Antipyretic activity of Tromaril as compared to aspirin-A clinical study. J. Assoc. Phy., India, 28 (Supplement): 109s-111s, 1980.  Back to cited text no. 1    
2.Lokabai, N. and Reddy, D. K.: Clinical trial of Tromaril (RH-8) in eplsiotomy. J. Assoc. Phys. India, 28 (Supplement): 112s-114s, 1980.  Back to cited text no. 2    
3.Lokabai, N. and Reddy, D. K.: A double blind non-cross ever study of Tromaril. oxyphenbutazone and placebo in episiotomy. J. Assoc. Phys. India, 28 (Supplement): 118s-120s, 1980.  Back to cited text no. 3    
4.Massi, A. T. and Medsger, T. A. Jr.: Epidemiology of the rheumatic diseases. In, "Arthritis and Allied Conditions-A Text-book of Rheumatology" 9th edition. Editors: D. J. McCarty, Henry Kimpton Publishers, London, 1979, p. 13.  Back to cited text no. 4    
5.Mathur, S. M., Itigi, A. and Begum Sogra: Clinical trial of tromaril (RH-S) in arthritis. J. Assoc. Phys. India, 28: (Supplement): 94s-97s, 1980.  Back to cited text no. 5    
6.Punjabi, Janki, Krishna, Usha, R., Paul, T. and Sheth, U. K.: A comparative study of tromaril, oxyphenbutazone and placebo in episiotomy-a double blind non-cross-over clinical study. J. Assoc. Phys. India, 28 (Supplement) : 115s-117x. 1980.  Back to cited text no. 6    
7.Rao, G. N.: Preliminary trial of tromaril in rheumatoid arthritis and arthralgia. J. Assoc. Phys. India, 28 (Supplement): 90s-93s, 1980.  Back to cited text no. 7    
8.Rao, G. N., Jain, S., Itigi, A. and Begum Sogra: Double blind cross-over study of tromaril (Rh-8) and oxyphenbutazone in various types of arthritis and arthralgia. J. Assoc. Phys. India, 28 (Supplement): 105s,-108s, 1980.  Back to cited text no. 8    
9.Sattur, G. B., Channappa, N. K. and Rajendra, B. D.: Use of tromaril (Rh-8) in rheumatoid arthritis, J. Assoc. Phys. India, 2S (Supplement) : 98s-104s, 1930.   Back to cited text no. 9    
10.Sisodia, P., Ebenezer, E. S., Rao, R. T., Bratt, K. G. S., Sheth, U. K., Hashim, R. and Sattur, P, B.: Pharmacological studies of tromaril (Rh-8)-a new anti-inflammatory drug. J. Assoc. Phys. India, 28 (Supplement): lls-25s, 1980).  Back to cited text no. 10    
11.Sisodia, P., Rao, V. P. V., Rao, S. P. and Sattur, P. B.: Toxicological studies of tromaril (Rh-8). J. Assoc. Phys. India, 28 (Supplement): 26s-35s, 1980.  Back to cited text no. 11    
12.Swami, 1V. P.. V., Itigi, A., Palsikar, R., Murthy, N. and Sisodia, P.: A pilot clinical study of tromaril in various types of arthritis and arthralgia, J. Assoc. Phys. India, 28 (Supplement): 87s-98s, 1980.   Back to cited text no. 12    
13.Wintrobe, M, M., and Landsberg, J. W.. A standardized technique for the blood sedimentation test. Amer. J. Med. Sci, 189: 162-115, 1935.  Back to cited text no. 13    

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow